United States· US:0135-0461_4d51b8f1-a819-7ff6-e063-6294a90a82bc
ALLI
A orlistat product containing orlistat, registered in United States by Haleon US Holdings LLC. The same ATC class is registered in 16 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Orlistat is registered in 16 of 19 countries.
Countries holding a registration under ATC A08AB01 (orlistat), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Orlistat · ATC A08AB01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of orlistat costs, country by country.
Normalised to the WHO defined daily dose (0.36 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Orlistat · price per daily dose (0.36 g)
USD · FX 28 Sept 2026
- CH Switzerland$3.08
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ORLISTAT
- Manufacturer
- Haleon US Holdings LLC
- Country
- United States (US)
- ATC code
- A08AB01
- ATC class
- Orlistat
- Defined daily dose
- 0.36 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc11013504610160 CAPSULE in 1 BOTTLE (0135-0461-01)
- ndc110135046105120 CAPSULE in 1 BOTTLE (0135-0461-05)
- ndc110135046106170 CAPSULE in 1 BOTTLE (0135-0461-06)
- ndc110135-0461-01
- ndc110135-0461-05
- ndc110135-0461-06
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
374 interactions on record for orlistat.
Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Orlistat · interactions on record
374 records
- 9 severe
- 117 moderate
- 8 minor
- 238 info
Most severe, free to view
- TriheptanoinA16AX17severe
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- PexidartinibL01EX15severe
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Orlistat in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaALLIHALEON IRELAND DUNGARVAN LIMITED, Waterford
- SpainALLI 60 mg CAPSULAS DURASHaleon Ireland Dungarvan Limited
- FinlandAlliHaleon Ireland Dungarvan Limited
- United KingdomAlli 60mg capsulesHaleon UK Trading Ltd
- BelgiumAlli 60 mgHaleon Ireland Dungarvan
- Swedenalli 60 mg Kapsel, hårdHaleon Ireland Dungarvan Ltd
- IrelandAlli 60 mg hard capsulesGlaxoSmithKline Dungarvan Limited
- IcelandalliGlaxoSmithKline Dungarvan Ltd.
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Belgium · Orlistat Sandoz, Orlistat Teva
- Czechia · Orlistat 1 A Pharma, Orlistat Sandoz
- Germany · Orlistat 1 A Pharma, Orlistat Hexal
- Denmark · Orlistat Accord, Orlistat Rivopharm
- Estonia · Orlistat Sandoz
- Spain · Beacita, Elimens
- Finland · Orlistat Sandoz, Orlistat Stada
- France · Orlistat Eg
- United Kingdom (Northern Ireland) · Orlistat, Orlistat Accord-Uk
- Ireland · Orlistat Accord
- Iceland · Alli, Xenical
- Italy · Beacita
- Liechtenstein · Alli, Xenical
- Lithuania · Orlistat Polpharma
- Latvia · Orlistat Polpharma
- Netherlands · Orlistat Sandoz
- Norway · Alli, Orlistat Accord
- Portugal · Orlistato Beacita, Orlistato Ciclum
- Sweden · Beacita, Orlistat Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/edd157d6-6e18-443d-b73e-f7eed31bd103 GET /v1/drugs/edd157d6-6e18-443d-b73e-f7eed31bd103?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "60",
"substance": "ORLISTAT",
"productndc": "0135-0461",
"dosage_form": "CAPSULE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA021887",
"marketing_category": "NDA"
}See everything about orlistat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.